(Q57313061)

English

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

article published in 2011

In more languages

Statements

scholarly article

0 references

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment (English)

0 references

0 references

atrial fibrillation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

object named as

R. M. Califf

0 references

Graeme J. Hankey

8

object named as

G. J. Hankey

0 references

author name string

K. A. A. Fox

1

0 references

J. P. Piccini

2

0 references

D. Wojdyla

3

0 references

R. C. Becker

4

0 references

J. L. Halperin

5

0 references

C. C. Nessel

6

0 references

J. F. Paolini

7

0 references

K. W. Mahaffey

9

0 references

M. R. Patel

10

0 references

D. E. Singer

11

0 references

publication date

28 August 2011

0 references

European Heart Journal

0 references

32

0 references

19

0 references

2387-2394

0 references

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

The HAS-BLED score and renal failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Quality of care for atrial fibrillation among patients hospitalized for heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Underuse of oral anticoagulants in atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR342

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHR342

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57313061&oldid=1875293734"